FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894955927> ?p ?o ?g. }

• W2894955927 endingPage "3231" @default.
• W2894955927 startingPage "3203" @default.
• W2894955927 abstract "To assess the comparative efficacy of short-acting muscarinic antagonists (SAMAs), long-acting muscarinic antagonists (LAMAs), LAMA in combination with long-acting beta-agonists (LABAs; LAMA/LABAs) and inhaled corticosteroids (ICS) in combination with LABA (ICS/LABAs) for the maintenance treatment of COPD.We systematically reviewed 74 randomized controlled trials (74,832 participants) published up to 15 November 2017, which compared any of the interventions (SAMA [ipratropium], LAMA [aclidinium, glycopyrronium, tiotropium, umeclidinium], LAMA/LABA [aclidinium/formoterol, indacaterol/glycopyrronium, tiotropium/olodaterol, umeclidinium/vilanterol] and ICS/LABA [fluticasone/vilanterol, budesonide/formoterol, salmeterol/fluticasone]) with each other or with placebo. A random-effects network meta-analysis combining direct and indirect evidence was conducted to examine the change from baseline in trough FEV1, transition dyspnea index, St George's Respiratory Questionnaire and frequency of adverse events at weeks 12 and 24.Inconsistency models were not statistically significant for all outcomes. LAMAs, LAMA/LABAs and ICS/LABAs led to a significantly greater improvement in trough FEV1 compared with placebo and SAMA monotherapy at weeks 12 and 24. All LAMA/LABAs, except aclidinium/formoterol, were statistically significantly better than LAMA monotherapy and ICS/LABAs in improving trough FEV1. Among the LAMAs, umeclidinium showed statistically significant improvement in trough FEV1 at week 12 compared to tiotropium and glycopyrronium, but the results were not clinically significant. LAMA/LABAs had the highest probabilities of being ranked the best agents in FEV1 improvement. Similar trends were observed for the transition dyspnea index and St George's Respiratory Questionnaire outcomes. There were no significant differences in the incidences of adverse events among all treatment options.LAMA/LABA showed the greatest improvement in trough FEV1 at weeks 12 and 24 compared with the other inhaled drug classes, while SAMA showed the least improvement. There were no significant differences among the LAMAs and LAMA/LABAs within their respective classes." @default.
• W2894955927 created "2018-10-12" @default.
• W2894955927 creator A5007239888 @default.
• W2894955927 creator A5017517266 @default.
• W2894955927 creator A5027220951 @default.
• W2894955927 creator A5032702133 @default.
• W2894955927 creator A5064988234 @default.
• W2894955927 creator A5066156405 @default.
• W2894955927 creator A5069229172 @default.
• W2894955927 date "2018-10-01" @default.
• W2894955927 modified "2023-09-29" @default.
• W2894955927 title "Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis" @default.
• W2894955927 cites W1433900029 @default.
• W2894955927 cites W1553966959 @default.
• W2894955927 cites W1575601674 @default.
• W2894955927 cites W1637753636 @default.
• W2894955927 cites W1688903512 @default.
• W2894955927 cites W1704063072 @default.
• W2894955927 cites W1802331233 @default.
• W2894955927 cites W1899462582 @default.
• W2894955927 cites W1969836944 @default.
• W2894955927 cites W1971649226 @default.
• W2894955927 cites W1972190609 @default.
• W2894955927 cites W1981197711 @default.
• W2894955927 cites W1989738601 @default.
• W2894955927 cites W2005640821 @default.
• W2894955927 cites W2006193143 @default.
• W2894955927 cites W2011096338 @default.
• W2894955927 cites W2017287154 @default.
• W2894955927 cites W2025133561 @default.
• W2894955927 cites W2026585673 @default.
• W2894955927 cites W2029238181 @default.
• W2894955927 cites W2029276834 @default.
• W2894955927 cites W2030987445 @default.
• W2894955927 cites W2032176613 @default.
• W2894955927 cites W2037965009 @default.
• W2894955927 cites W2039237831 @default.
• W2894955927 cites W2039748217 @default.
• W2894955927 cites W2044624199 @default.
• W2894955927 cites W2047124405 @default.
• W2894955927 cites W2047130491 @default.
• W2894955927 cites W2048919604 @default.
• W2894955927 cites W2051449385 @default.
• W2894955927 cites W2056040906 @default.
• W2894955927 cites W2057984874 @default.
• W2894955927 cites W2058580481 @default.
• W2894955927 cites W2070935883 @default.
• W2894955927 cites W2082198827 @default.
• W2894955927 cites W2084702877 @default.
• W2894955927 cites W2091808438 @default.
• W2894955927 cites W2095244193 @default.
• W2894955927 cites W2098643589 @default.
• W2894955927 cites W2098923148 @default.
• W2894955927 cites W2105234929 @default.
• W2894955927 cites W2105402505 @default.
• W2894955927 cites W2107045802 @default.
• W2894955927 cites W2109747510 @default.
• W2894955927 cites W2110432885 @default.
• W2894955927 cites W2111149721 @default.
• W2894955927 cites W2112318617 @default.
• W2894955927 cites W2116505643 @default.
• W2894955927 cites W2116894543 @default.
• W2894955927 cites W2120698097 @default.
• W2894955927 cites W2123772853 @default.
• W2894955927 cites W2123850585 @default.
• W2894955927 cites W2125779455 @default.
• W2894955927 cites W2128278745 @default.
• W2894955927 cites W2128643475 @default.
• W2894955927 cites W2129633626 @default.
• W2894955927 cites W2130795051 @default.
• W2894955927 cites W2132170452 @default.
• W2894955927 cites W2133080325 @default.
• W2894955927 cites W2134091333 @default.
• W2894955927 cites W2141034778 @default.
• W2894955927 cites W2142449488 @default.
• W2894955927 cites W2142633372 @default.
• W2894955927 cites W2142724633 @default.
• W2894955927 cites W2144805491 @default.
• W2894955927 cites W2149199480 @default.
• W2894955927 cites W2151427273 @default.
• W2894955927 cites W2153441442 @default.
• W2894955927 cites W2163317499 @default.
• W2894955927 cites W2167941825 @default.
• W2894955927 cites W2171280425 @default.
• W2894955927 cites W2171697174 @default.
• W2894955927 cites W2171974515 @default.
• W2894955927 cites W2172492020 @default.
• W2894955927 cites W2202263951 @default.
• W2894955927 cites W2226497786 @default.
• W2894955927 cites W2313271471 @default.
• W2894955927 cites W2344252281 @default.
• W2894955927 cites W2345348650 @default.
• W2894955927 cites W2365138737 @default.
• W2894955927 cites W2496257167 @default.
• W2894955927 cites W2511390233 @default.
• W2894955927 cites W2553006813 @default.
• W2894955927 cites W2579827621 @default.
• W2894955927 cites W2588681363 @default.

• next